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Abstract

Introduction: Physician-assisted suicide (PAS) is an end of life (EOL) option that involves a
patient ingesting a lethal medication that has been prescribed by a physician after a complex
vetting process. In certain countries and the United States (US) where PAS is legal, patients
avoid EOL suffering and may have more control over the dying process.
Scholarly Inquiry Question: Do patients who seek end-of-life care by means of PAS have a
greater sense of control of their dying process versus those patients who do not or are not
allowed to participate in PAS?
Supporting Evidence: Physical and emotional suffering are significant motivators for terminally
ill patients to desire PAS (Nissim et al., 2009; Johansen et al., 2005; Maessen et al., 2009; Regan
et al.). Through PAS, patients are also able to control the circumstances of their death, including
the time of death, location, rituals, and individuals present (Maessen et al., 2009; Smith et al.,
2011). Healthcare providers play a critical role in treating terminally-ill patients and upholding
patient autonomy; non-judgmental and timely communication are the foundation for discussing
PAS (Georges et al., 2007; Pasman et al., 2013). Suffering while dying is subjective (Dees et al.,
2010); PAS is an EOL option that upholds the ethical principle of autonomy(Nissim et al., 2009).
Theory and Conceptual Framework: The Theory of Relational Autonomy was used to guide this
integrative literature review. The goal of this theory is to build social relationships and
institutions that encourage individuals to lead self-governing lives (Mackenzie, 2015).
Conclusions: Terminal illness is life-altering. PAS contributes to a better quality of death and
upholds patient autonomy by allowing the patient to die on their own terms: deciding who is
present, where and when their death will take place, and ultimately ending the process of painful
and undignified lingering.
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Introduction

In 1994, Oregon was the first state in the United States to legalize physician-assisted
suicide (PAS) for terminally ill adults with a voter-supported initiative called the Death With
Dignity Act (Volker, 2007). The 2018 annual report from the Oregon Health Authority (OHA)
has been summarized by the organization Death with Dignity (DWD); this report revealed that
168 people in Oregon used lethal medications obtained under the law in 2018, with a death rate
of 49.5 of 10,000 deaths. Of the people who participated in physician-assisted suicide, the
majority had cancer (62.5%), were actively in hospice care (90.5%), and died at home (88.6%).
With regard to end-of-life concerns motivating them to participate in PAS, patients reported the
loss of autonomy (91.7%), decreased capability to be involved in activities that made life
enjoyable (90.5%), and loss of dignity (66.7%) were prime factors (DWD, 2019). Oregon will
be referenced frequently throughout this paper; it is considered the “laboratory” of the U.S. with
regard physician-assisted suicide legislation (Volker, 2007).
In 1997, the Supreme Court of the United States ruled that each state may independently
decide to legalize physician-assisted suicide (Volker, 2007). Since this ruling, several other
states have chosen to pass legislation similar to Oregon’s Death with Dignity Act; in June 2019,
Maine became the eighth state to legalize PAS (Villenueve, 2019). With 18 states also
considering PAS (Villenueve, 2019), the discussion surrounding physician-assisted suicide is
acutely relevant to the medical community in the United States. Despite the possible discomfort
surrounding a medical option that shortens rather than prolongs life, understanding and forming
an opinion about PAS is vital for healthcare providers who participate in conversations with their
patients about end-of-life options.
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Background

Physician-assisted suicide (PAS) is defined as the use of a lethal prescription medication
from a licensed physician that is ingested by the patient on their own power with the intent of
ending their life (Shibata, 2017). PAS differs from euthanasia for which euthanasia is defined as
an event when a medication is administered by a third party with the intention of ending the
person’s life at his or her request (Chapple, Ziebland, McPherson, & Herxheimer, 2006). Some
studies use “aid-in-dying” as an umbrella term for both PAS and euthanasia; aid-in-dying is also
used to simply reference the act of the medical community assisting in shortening the life of the
patient.
Using Oregon as an example, patients who are interested in PAS must meet specific
criteria, according to the Physician Aid-in-Dying Clinical Committee and Oregon Death with
Dignity Act of 1994, Chapter 127. Per the Act, the patient must be over the age of 18, show
proof of residency in the State of Oregon (via a driver’s license, lease agreement, tax return, or
voter registration), be capable of making major medical decisions as determined by their
physician, and have a terminal diagnosis or a type of medical condition for which the outcome
would be death within six months or less (1994). Capable is defined as “in the opinion of a court
or in the opinion of the patient’s healthcare provider or consulting physician, psychiatrist or
psychologist, a patient has the ability to make and communicate health care decisions to health
care providers, including communication through persons familiar with the patient’s manner of
communicating if those persons are available” (Oregon Death with Dignity Act, 1994, p. 1).
Healthcare provider (HCP) will be used to include any physician or advanced practice provider
primarily caring for the patient during end of life.
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Upon a patient’s request for PAS, the healthcare provider is required to ask questions to
assess for any physical, psychological, financial, social, and spiritual issues that could be
influencing the patient’s request. The goals of the initial assessment by the HCP are to prevent
premature action by the patient, ensure the patient is making the request free from external
pressure, and to make certain that the patient is considering or has considered alternatives to
PAS. The decision to participate in PAS must be voluntary and intentional, meaning the patient
understands that their participation of such acts will result in the ending of their life. If the
healthcare provider is concerned for the presence of mental health conditions influencing the
patient’s decision, the physician shall refer the patient to a licensed psychiatrist for a thorough
evaluation (Oregon Death with Dignity Act, 1994; Orentlicher, Pope, & Rich, 2016).
According to the Oregon Death with Dignity Act, the attending physician is the primary
physician (healthcare provider) who is caring for and treating the patient’s terminal illness
(1994). The HCP is not required to obtain a special license to prescribe lethal medications for
PAS. Should a patient request PAS, the healthcare provider has the right to refuse to participate
in such events. If the primary healthcare provider declines to be involved in PAS, the patient’s
care and medical records would be transferred to a new healthcare provider who provides
services associated with PAS (Oregon Death with Dignity Act, 1994). When patients are seen
and evaluated by a healthcare provide, this evaluation serves as clearance for the patient to make
this type of serious decision. Thus, healthcare providers are participating in good-faith
compliance with Oregon’s Death with Dignity Act, and they are protected from any criminal
liability or professional disciplinary action (1994).
As with other major medical procedures, the healthcare provider must establish informed
consent. This is accomplished by the healthcare provider making the patient aware of other end-
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of-life options such as hospice care, aggressive symptom management, the voluntary cessation of
oral intake, discontinuing life-sustaining treatment, and palliative sedation (Oregon Death with
Dignity Act, 1994; Orentlicher et al., 2016). The healthcare provider must also inform the
patient that the lethal prescription medication will almost certainly cause death; the medication
potentially induces vomiting, which can, rarely, result in failure to cause death; the patient can
refuse PAS at any time; the HCP will care for the patient regardless of the patient’s decision to
participate in PAS; and the patient must be physically able to ingest the medication
independently or inject the medication in their feeding tube. Family may only help the patient by
mixing the medication in a cup but are not allowed to administer the lethal dose of medication.
The healthcare provider must document the patient’s understanding of each item to show proof
of informed consent (Oregon Death with Dignity Act, 1994; Orentlicher et al., 2016).
The healthcare provider is required to refer the patient to a consulting healthcare provider
who is qualified by specialty or experience to assess the patient and make both a prognosis and
diagnosis about the patient’s disease. “A consulting physician shall examine the patient and his
or her relevant medical records and confirm, in writing, the [healthcare provider’s] diagnosis that
the patient is suffering from a terminal disease, and verify that the patient is capable, is acting
voluntarily and has made an informed decision” (Oregon Death with Dignity Act, 1994, p. 4).
Continuing to use Oregon as a model, the patient must make two verbal requests for PAS
to their healthcare provider, at least fifteen days apart (Orentlicher et al., 2016; Volker, 2007).
The patient must also present a written request (see Appendix), witnessed by two individuals
who sign the request for PAS form in the presence of the patient and attest to the patient acting
voluntarily, having the mental capacity, and not being coerced into signing the request for PAS
(Oregon Death with Dignity Act, 1994). The witnesses cannot be a relative, a financial

Autonomy and Physician-Assisted Suicide

8

beneficiary, the healthcare provider, or a staff member of the institution where the patient is
receiving care (Oregon Death with Dignity Act, 1994). Encouraging the patient to include his or
her family in the decision-making process is recommended but not required (Oregon Death with
Dignity Act, 1994). If the patient qualifies for PAS, the healthcare provider writes the
prescription for the lethal medication, which is then dispensed by a pharmacist or the healthcare
provider (Volker, 2007).
In Oregon, over one-third of patients who receive a lethal prescription choose not to
ingest the medication, for reasons that are not documented (Orentlicher et al., 2016). A literature
search performed by Willem, Groenewoud, and van der Wal looked at the various medications
used in physician-assisted death, which includes PAS and euthanasia (1999). This study found
that over forty medications had been used in physician-assisted death. Most of the literature in
this study came from the Netherlands, and the medication regimen for PAS varied across HCPs
and institutions. Thirty percent of patients received one medication, either an opioid or
barbiturate; 57% received two medications, typically a barbiturate or a benzodiazepine with a
neuromuscular relaxant. Other medications that have been utilized include propofol, ketamine,
insulin, and potassium. However, the recommendation for PAS is 9g of a short-acting
barbiturate, either secobarbital or pentobarbital, which is what has been used in the United States
(Orentlicher et al., 2016; Willem, Groenewoud, & van der Wal, 1999).
In physician-assisted suicide, the patient must take the medication independently. The
ingestion process starts with the administration of an anti-emetic such as Reglan
(metoproclamide) or Zofran (ondansetron) to prevent nausea. About an hour later, the patient
mixes eight ounces of water with the barbiturate. The patient then must ingest the entire mixture
quickly to prevent falling asleep and risk not getting the full dose of the medication; the patient
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goes into a comatose state which leads to respiratory suppression with the end result of death.
In Oregon and Washington State, the healthcare provider cites “respiratory failure” as the cause
of death on the death certificate to maintain patient confidentiality (Orentlicher et al., 2016).
The Netherlands is seen as the global leader in setting the precedent for physicianassisted suicide and euthanasia. According to Rietjens, van der Maas, Onwuteaka-Philipsen, van
Delden, and van der Heide, the history of aid-in-dying in the Netherlands began in 1973, when a
physician’s mother repeatedly requested assistance in dying following a debilitating stroke
(2009). The physician chose to help her mother die via lethal medication; the physician was
subsequently prosecuted and found guilty of committing murder. This case initiated the
conversation about the medical community’s conflicting role in relieving suffering while doing
no harm (Rietjens, van der Maas, Onwuteaka-Philipsen, van Delden, & van der Heide, 2009).
Physician-assisted suicide and euthanasia were regularly practiced in the Netherlands throughout
the 1980s and 1990s, but the fear of prosecution caused an absence of transparency from the
medical community regarding end-of-life treatment. Each reported case was scrutinized closely,
and the court decided whether to prosecute the healthcare provider. The Euthanasia Act was
passed in 2002 to officially legalize the practice of aid-in-dying and protect healthcare providers,
but mainly legalized an existing practice. Since passing The Euthanasia Act in 2002, most
healthcare providers in the Netherlands report an increase in legal certainty and care in the dying
patient (Rietjens et al., 2009).
Physician-assisted suicide is also legal in Switzerland, Belgium, and Canada (Hurst,
Zellweger, Bosshard, & Bopp, 2018). In Switzerland, assisted suicide has been legal since 1918,
if altruism is the motivation for helping someone end their own life (Hurst & Mauron, 2003). In
Canada, PAS was legalized in 2015 following the British Columbia Supreme Court Case, Carter

Autonomy and Physician-Assisted Suicide

10

vs Canada, in which two terminally ill women were granted the right to end their own lives
(Supreme Court of Canada, 2016). Like the Netherlands, aid-in-dying was regularly practiced
and considered a patient’s right in Belgium decades before it was formally legalized in 2002
(Saad, 2017). In the United States, PAS is legal in Oregon, Maine, Vermont, Washington,
Montana, California, Washington D.C., and Bernalillo County in New Mexico (Shibata, 2017;
DWD, 2019).
The criteria to qualify for PAS in both the Netherlands and Belgium are similar to
Oregon, except the healthcare provider must also believe the patient is suffering unbearably and
hopelessly (Pasman, Willems, Onwuteaka-Philipsen, 2013). Suffering as a motivation to
participate in aid-in-dying is frequently cited in the data surrounding end-of-life decisionmaking. An integrative review by Dees, Vermooij-Dassen, Dekkers, and van Weel concluded
that a true definition of patient suffering in the context of a request for PAS or euthanasia does
not exist due to its subjectivity (2010). For the purposes of this paper, their conceptual definition
of suffering will be used: “Unbearable suffering in the context of a request for euthanasia or
physician-assisted suicide is a profoundly personal experience of an actual or perceived
impending threat to the integrity or life of the person, which has a significant duration and a
central place in the person’s mind” (Dees, Vernooij-Dassen, Dekkers, & van Wheel, p. 350,
2010). While family members and medical professionals may also undergo suffering, this paper
will focus on the patient experience up until death.
During the dying process, suffering and relief from suffering vary between different
terminal illnesses, as do the motivations for desiring a hastened death. Pierson, Curtis, and
Patrick found that patients dying from AIDS longed for a “good death,” wanting complete pain
control, avoiding prolonged dying via life support, and desiring intact bodily functions (2002).
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Patients with amyotrophic lateral sclerosis (ALS) in the Netherlands feared choking to death as
their bodies slowly lost control of basic, involuntary functions (Maessen et al., 2009). After
witnessing their loved ones deteriorate and die from the same genetic disease, individuals in the
early stages of Huntington’s disease also feared suffering through losing physical function and a
sense of self (Regan et al., 2017). Patients with advanced cancer viewed the option of hastening
death in the future as reassuring for the present, allowing them to imagine a sense of control and
autonomy (Nissim, Gagliese, & Rodin, 2009).
Upholding the ethical principle of autonomy is a frequently cited reason for ensuring
access to physician-assisted suicide. In Principles of Biomedical Ethics, Beauchamp and
Childress define personal autonomy as “self-rule that is free from both controlling interference
by others and from limitations, such as inadequate understanding, that prevent meaningful
choice” (p. 58, 2001). In medicine, the right to autonomy has been used by competent patients to
refuse or request treatment (Shibata, 2017). Personal autonomy is often referenced with regard
to physician-assisted suicide, because limiting a patient’s ability to choose aid-in-dying is forcing
the patient to participate in a dying process that is usually filled with pain and suffering.
Denying anyone relief from this type of suffering could be considered violation of the patient’s
ethical principle of autonomy (Shibata, 2017). PAS is illegal in most states and countries around
the world, severely limiting patient’s access to this end-of-life options. Some patients do travel
in order to participate in physician-assisted suicide in places where it is legal. However, in a
qualitative study exploring Huntington’s disease, participants in the United Kingdom report the
mutually conflicting conditions of being healthy enough to go to Switzerland but ill enough to
meet the criteria to qualify for PAS, in addition to difficulties of needing the money to travel and
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dying in a strange country without a large number of friends or family present (Regan, Preston,
Eccles, & Simpson, 2017).
As modern medicine evolves, discussing end-of-life options such as physician-assisted
suicide become increasingly relevant. Some may consider PAS to be healthcare providers
“playing God;” however, with medical marvels such as chemotherapy, intubation and ventilator
support, feeding tubes, antibiotics, and vasopressors, life is being extended beyond its previous
natural endpoint. In addition to focusing on keeping people alive, the medical community must
also ask the uncomfortable questions about their role in helping patients die with dignity and
respect.
Purpose
The purpose of this scholarly inquiry paper is to explore the patient-experience
surrounding physician-assisted suicide, particularly with regard to the ethical principle of
autonomy. A large body of research has been performed on the moral dilemma nurses and
healthcare providers face surrounding PAS, focusing on the healthcare professionals rather than
the patient. As PAS continues to be introduced to state legislatures across the United States,
misinformation and moral outrage also eclipse the patient perspective. In keeping with the
practice of medicine, the patient’s end-of-life wishes and experience should drive the discussion
surrounding physician-assisted suicide.
Scholarly Inquiry Question
To guide the literature search for this topic, a clinical question was developed using the
Population (P), Intervention (I), Control (C), Outcome (O), PICO, method. The clinical question
is as follows: Do patients who seek end-of-life care by means of PAS have a greater sense of
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control of their dying process versus those patients who do not or are not allowed to participate
in PAS?
Method Used for Inquiry
A traditional, or narrative, literature review was the method used to guide this inquiry;
this type of review is used to synthesize and summarize a large volume of data on a specific topic
(Cronin, Ryan, & Coughlan, 2008). The purpose of a traditional literature review is to not only
provide a thorough background on a specific subject but also reveal areas requiring further
research (2008). The steps to writing this type of literature review include selecting a review
topic, searching the literature, analyzing and synthesizing the literature, and writing the review
(2008). Following the completion of this paper, the interpretations of the literature review will
provide further recommendations and will be presented to faculty at Winona State University in
April, 2020.
Literature Review
Database Search
A literature search was conducted through CINAHL/Ebsco World Host and The
Cochrane Library (Table 1) using the following key words: Patient experience, physicianassisted suicide, quality of life, and quality of death. Data was limited to publication between the
years 2000 and 2019. Excluded sources include those articles that were not in English language,
duplicates of previously found articles, or articles in which physician-assisted suicide or
euthanasia occurred in the event of diseases which were not terminal (i.e. Alzheimer’s disease,
dementia, or chronic mental illness). Articles from the perspective of healthcare professionals
such as nurses or healthcare providers were excluded, and those from the perspective of the
patient or the patient’s proxies were included. Articles from proxies were included only if the

Autonomy and Physician-Assisted Suicide

14

researcher was examining the patient’s dying experience from the perspective of the patient
proxies. Excluded were articles with low levels of evidence, specifically those based on expert
opinion or discussions of the legal and ethical dilemmas facing providers participating in
physician-assisted suicide as they are not relevant to the patient experience of PAS. Of the
remaining articles, 37 were reviewed, and 13 were included due to their quality, relativity to the
patient perspective on the use of physician assisted suicide, and diversity of data from the United
States and countries in Europe.
Review of the Literature
Thirteen articles were reviewed, in-depth (Table 2), and the information has been
organized by themes. Each heading within this section will reference a theme, and the evidence
from the included studies will be synthesized accordingly. Of note, the data is limited by two
factors: 1) Due to the nature of the topic, the patient is unable to be interviewed about his or her
experience posthumously and 2) Studying physician-assisted suicide is restricted to the few
countries and states where it has been made legal; thus, the evidence is limited to specific
cultures, religions, and geographic areas. The results may not be generalizable.
Some of the articles from countries where both PAS and euthanasia are legal do not
differentiate between the two practices. In addition, participants in the study performed by
Pierson et al. have a terminal diagnosis of AIDS. This study was published in 2002; medical
advancements over the last eighteen years have remarkably improved outcomes for patients
living with HIV/AIDS. Though dying of AIDS is unlikely in 2020, the results of the patients’
dying experience in this qualitative study are still relevant to this paper.
Themes from the Literature
Patient motivations for participating in physician-assisted suicide.
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Physical suffering.
Avoiding physical suffering was a frequent motivation for patients with terminal illnesses
who desired a hastened death. This section will be divided by disease process.
Patients with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and
Huntington’s disease primarily experience physical suffering related to loss of voluntary and
involuntary muscle functioning. Patients in the early stages of Huntington’s disease reported
witnessing close relatives die slowly, which caused them to view participating in PAS for
themselves as an imperfect but necessary solution until a cure is found. They describe the
process as being “locked in,” existing but unable to speak, eat, or do anything for one’s self
(Regan et al., 2017). “They have in no way been able to sustain her quality of life. And, as a
result I don’t see it as a triumph that she is still breathing” (Regan et al, p. 711, 2017).
Maessen et al. found that the most common physical reason (70%) for ALS patients to
participate in PAS was a fear of choking. Pain was not cited as a reason for hastening death
(2009); however, in a study measuring patient interest in PAS as reported to the caregiver,
Ganzini, Silveira, and Johnston found that choking episodes and severity were not significant
motivations, rather severe insomnia, frequent pain, and discomfort other than pain as statistically
significant motivations for discussing PAS (2002). A limitation to the study by Ganzini et al. is
the accuracy of the caregivers’ reports of the patients’ interest (2002); thus, choking in patients
with ALS is still considered a physical motivation for participating in PAS.
Patients with a terminal cancer diagnosis describe fear of future pain and experiences
with present or past pain as motivations for participating in aid-in-dying. During a study
exploring the attitudes of dying cancer patients toward euthanasia or PAS, Johansen, Hølen,
Kaasa, Loge, and Materstvedt found that patients had a significant fear of pain, and previous

Autonomy and Physician-Assisted Suicide

16

exposure to pain caused a fear of future pain (2005). “It is the pain that I am most afraid of…
My only hope is to have no pain” (Johansen, Hølen, Kaasa, Loge, & Materstvedt, p. 456, 2005).
A longitudinal study of patients with advanced lung and gastrointestinal cancers found that 89%
of participants contemplated hastening death through PAS or euthanasia as a future exit plan
based on fears of experiencing severe pain during the final dying phase (Nissim et al., 2009).
When pain is severe, it consumes all of the attention of the patient (Johansen et al., 2005),
leaving the patient unable to focus on anything but the pain (Nissim et al., 2009). A desire for
PAS would surface, as death is preferable to a prolonged state of severe pain (Johansen et al.,
2005; Nissim et al., 2009). However, when the pain was alleviated, the motivation for a
hastened death would diminish (Johansen et al., 2005). Thus, desire to participate in PAS could
fluctuate with the patient’s pain level. “[When the pain is alleviated] then I want to live a little
bit longer” (Johansen et al., p. 457, 2005). Severe pain also triggered the patients’ feelings of
despair (Nissim et al., 2009; Johansen et al., 2005).
Only one study in this review of literature focused on patients dying from AIDS, a
qualitative study exploring patients’ perceptions of a good death. Severity of pain was correlated
to the degree of the patient experiencing a “bad” death, and absence of pain was the most
commonly mentioned factor identifying a “good” death. None of the patients were indifferent to
the domain of symptom control. Several of the participants mentioned physician-assisted suicide
as a method of escaping unbearable pain and ensuring a “good death” (Pierson, Curtis, & Patrick,
2002). “There’s no point in keeping people in pain, or so doped up that they’re not aware of
anything, because that’s the only way you can keep them from being in pain, you know, alive,
just to be alive. That’s not living” (Pierson et al., p. 594, 2002).
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Dees et al. performed a systematic review to create an overview of descriptions of
unbearable suffering in the context of a request for euthanasia or physician-assisted suicide. The
55 articles included in the review showed that physical suffering from the patient’s perspective
included pain, weakness, and functional impairment as motivations to request aid-in-dying.
These experiences are inevitable during the terminal phase of an illness, and the irreversible
disintegration seemed to be the start of openly considering death as preferable to life (2010).
These motivations are consistent with the findings from Georges et al. who performed a
retrospective study into the history of the wishes of terminally-ill patients for aid-in-dying by
interviewing the relatives closest to the patient. The two most commonly cited physical reasons
were pain (42%) and dyspnea (26%) (2007).
Physical suffering in the terminal phase of illness is unavoidable, regardless of illness.
This evidence reveals that physical suffering is a key motivator for patients to participate in
physician-assisted suicide. While aggressive symptom control and palliative care are strategies
to relieve patients’ distress, suffering in the face of death could be prolonged and persist until the
end of the patient’s life.
Emotional suffering.
In addition to physical suffering, emotional suffering during the terminal phase of illness
is complex, with multiple layers including anticipating death, becoming dependent on others, and
feelings of hopelessness or despair. This section will also be separated according to disease
process when applicable.
Ganzini, Silveira, and Johnston performed two studies in Oregon on the same patients with ALS,
both studies measuring patients’ motivations for aid-in-dying. The second study was performed
posthumously, asking patients’ relatives if the patient expressed interest in physician-assisted
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suicide in the last month of illness. The second study found that 67% of patients who discussed
wanting PAS in the last month of life had hopelessness scores of >9 on the Beck Hopelessness
Scale during the first study (Figure 1). Only 12% of patients who did not report an interest in
PAS in the last month of life had elevated hopelessness scores. Major depressive disorder did
not predict a desire to participate in PAS (2002).
Figure 1. Beck Hopelessness Scale

Figure 1. A 20 point questionnaire to assess hopelessness and suicidality in vulnerable
populations. Adapted from “Risk to self in psychiatry: Do suicide/self-harm scales help
clinicians?” by A. Mitchell, 2008, a lecture conducted at the Annual General Meeting of
the Royal College of Physicians, London.
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Several years later in the Netherlands, Maessen et al. had similar results when
researching ALS patients. Hopelessness was strongly associated with the decision to seek PAS
or euthanasia (p = 0.04), and no significant association existed between a diagnosis of depression
or depressive symptoms and euthanasia or PAS (2009). This suggests that hopelessness, and not
depression, is a motivator and predictor of patients desiring to participate in physician-assisted
suicide during the final stages of ALS.
Other significant motivators to participate in PAS found by Maessen et al. included that
the patient knew there was no chance of improvement, loss of dignity, and feeling dependent on
others, though feeling to be a burden on family or friends was not reported frequently (2009).
Similarly, patients with Huntington’s disease also contributed emotional suffering as a reason for
PAS, describing as a loss of self, explaining a fear of entering a persistent vegetative state,
losing not only complete physical functioning, but also one’s role, personality, meaning, and
community (Regan et al., 2017).
Nissim et al. found that all advanced cancer patients in the study experienced despair and
contemplated death as an escape. Many believed that hastening death was the only action that
would relieve strong feelings of despair, helplessness, and panic (2009). Future worries such as
pain, eventually losing hope, and potentially entering a persistent vegetative state influenced
cancer patients’ wishes for PAS (Johansen et al., 2005). Patients feel trapped by their disease
state, “I don’t want to wake up and face this… honestly I just pray that I would just die in my
sleep” (Nissim et al., p. 168, 2009).
When researching the relatives’ perspective on patients who died using euthanasia or
PAS, Georges et al. found loss of dignity to be the most expressed reason for patients to request
aid in dying (60%) (2007). Activities of daily living (ADL) dependency is also a significant
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motivator, along with the feelings of being a burden and hopelessness (Georges et al., 2007;
Dees et al., 2010). Dees et al. details the feelings of existential loss: independence, occupational
role, sexual desire, and personal status as significant emotional burdens driving patients to
participate in PAS (2010).
While many end-of-life options are focused on controlling physical suffering, these
studies reveal the immense emotional suffering experienced by individuals with terminal
illnesses. Physical suffering and emotional suffering are also linked; pain can influence feelings
of despair and hopelessness (Johansen et al., 2005; Nissim et al., 2009). Emotional suffering in
many forms is a significant motivator for patients to participate in physician-assisted suicide.
Economic Motivations in the United States.
The United States does not have a state-financed healthcare option for all residents,
potentially leading patients to desire physician-assisted suicide to avoid accumulating additional
illness-related bills. Emanuel, Fairclough, Slutsman, and Emanuel explored the economic
burden of terminal illness in the United States (2000). This study found a strong association
between economic burden and patients with substantial needs in four areas: transportation,
nursing care, homemaking, and personal care. Patients with substantial care needs were
significantly more likely to report that their care was a moderate or great economic hardship for
their family compared to patients with low care needs. In families of patients with substantial
care needs, 10% of the household income was spent on healthcare costs other than their
insurance premiums, and they or their family had to sell assets, take out a loan, or get an
additional job to pay for the patient’s healthcare. 14.9% of these patients had thought about or
expressed a desire for PAS compared with 8.2% of patients with low care needs (Emanuel,
Fairclough, Slutsman, & Emanuel, 2000).
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Quality of Life and Quality of Death.
In harmony with avoiding suffering as a motivation to participate in PAS, physicianassisted suicide could be an end-of-life option that can influence the patient’s quality end-of-life
and quality of death. 92% of relatives of patients who died using euthanasia or physicianassisted suicide in the Netherlands believed that assisted dying had increased the patient’s quality
end-of-life, and 100% of relatives reported that the patients were ready to die (Georges et al.,
2007).
Quality of Life.
Access to PAS is instrumental in promoting quality of life in patients with terminal
illness. Knowing that physician-assisted suicide is an option allows patients with terminal illness
to tolerate the present suffering (Nissim et al., 2009).
As a disease progresses, patient’s quality of life changes and compels many to desire
physician-assisted suicide. Dees et al. gives the example of a formerly athletic and energetic 62year-old woman who requested PAS after being diagnosed with metastatic ovarian cancer and
was facing physical frailty and regular hospitalizations (2010). Severe pain also significantly
effects patients’ quality of life in the terminal phase of illness (Dees et al., 2010; Johansen et al.,
2005; Nissim et al., 2009; Pierson et al., 2002). Patients who are refused access to PAS state that
they continue to desire death because of a poor quality of life, such as being physically unable to
do activities of enjoyment but are limited to sitting around and watching television (Pasma et al.,
2013).

Autonomy and Physician-Assisted Suicide

22

Patients can anticipate life changes due to the disease, even if in earlier stages of the
disease process. These life changes can include physical changes including pain, cosmetic
changes, side effects of medications; emotional changes due to the distress of the disease burden
and treatment options; and overall a different perspective of their life after being diagnosed with
such an illness. Patients with Huntington’s disease report knowing that they would not be able to
maintain their quality of life due to the impending disease progression, which caused them to
embrace assisted dying when the time came (Regan et al., 2017). These same patients reported
that their diagnosis also forced them to be intentional with their time and actions prior to their
death (2017).
Quality of Death.
Physician-assisted suicide can play a lead role in creating better quality of death.
Participants with advanced cancer perceived PAS as an option to avoid painful and undignified
lingering, which would in turn cause their family to linger with them (Nissim et al., 2009).
“Suicide is a way of exiting. I don’t want to talk about that because I like life, and I have lots to
live for, but if I come to the point when I am too weak to do anything, then I don’t want to stay”
(Nissim et al., p. 168, 2009). Patients with AIDS experienced similar feelings, concerned that
dying would inevitably include a long, drawn out process; physician-assisted suicide would
allow them to avoid that process, creating a ‘good’ death experience (Pierson et al., 2002). This
belief is echoed in patients with Huntington’s disease, believing that assisted dying embodies an
act of kindness (Regan et al., 2017). “Nan was just a vegetable by the end of it, bless her, she
was literally just a case. There was nothing left inside. We were keeping her alive, but what for?
She wasn’t getting any joy out of life” (Regan et al., p. 711, 2017). Thirty-three percent of
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patients in a study by Nissim et al. believed that physician-assisted suicide and euthanasia are
part of the medical community’s duty to relieve suffering (2009).
In a qualitative study exploring the lived experience of patients with AIDS, the majority
of participants felt as though having family members, friends, pets, and caregivers around during
the dying process would be an important contributor to creating a good death (Pierson et al.,
2002). For some, a reason to request euthanasia or PAS offers an opportunity to say good-bye to
their loved ones while remaining conscious (Georges et al., 2007), and patients who receive a
lethal prescription are more likely to have the opportunity to say goodbye than those who do not
participate in PAS (Smith, Goy, Harvath, & Ganzani, 2011). “I think dying alone, not having
anyone there to help make that crossing-over bearable, that would probably be the worst”
(Pierson et al., p. 591, 2002). This includes some desiring to have a religious figure present to
perform last rites (Pierson et al., 2002), though patients who participate in PAS are less likely to
engage in a spiritual ceremony than those who do not pursue PAS (Smith et al., 2011).
Pierson et al. found that patients also preferred to be in their own home, and this location
was correlated with a desire to have their loved ones present (2002). Patients with ALS who
participated in euthanasia or PAS most often died at home and with less anxiety, while patients
who were receiving sedatives were more likely to die at a nursing home or hospice (Maessen et
al., 2009). In a systematic review of literature by Gamondi, Fusi-Schmidhauser, Oriani, Payne,
and Preston, two sub-themes emerged when anticipating the final farewell: Patients who engaged
in assisted dying were able to organize end-of-life rituals, and patients were allowed to choose
the location of death (2019). Family members rated the quality of the moment of death as higher
in patients who engaged in PAS compared to those who did not (Smith et al., 2011).
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Physician-assisted suicide promotes dying with dignity, and patients view PAS as more
dignified than suicide (Nissim et al., 2009). In patients who did use euthanasia or PAS, dignity
in dying contributed to the patient having a better death experience, with 93% of relatives
reporting that their loved ones died peacefully (Georges et al., 2007). Physician-assisted suicide
can significantly influence the quality of life and death in patients with terminal illnesses.
Patient-physician communication about end-of-life wishes.
Healthcare providers licensed to prescribe lethal prescriptions are the gateway to
participating in physician-assisted suicide. Therefore, open communication and building a
positive relationship between patient and HCPs is central to ensuring patient input about their
end-of-life wishes. Having a good relationship with one’s HCP increases the patient’s feeling
that they are receiving quality medical care (Pierson et al., 2002). In addition, the HCP is
responsible for ensuring patient understanding of every available end-of-life option, and
miscommunications could result in missed opportunities to relieve patient suffering.
Timing.
As explained in the introduction, there is a complex process that takes place between a
patient’s request for physician-assisted suicide and receiving the prescription. Understanding the
patient’s wishes as early as possible will help to guide the provider and ensure the patient
receives care in a timely manner. Many patients will disclose their wish for a hastened death to
their loved ones earlier than to their healthcare provider. Ganzini et al. found that ALS patients
made explicit requests for PAS to their HCPs in the last month of life but had discussed
considering PAS as an end-of-life option to their caregivers in previous months (2002). A study
by Georges et al. reports that 79% of patients expressed their wishes about end-of-life decisions
to their partners (69%) or children (38%) before they became terminally ill, but only 33% of
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patients spoke to their physician about their wishes prior to becoming terminally-ill (2007).
Most explicit requests were made within three months of the patient’s death, with 29% of
requests being made in the last week of life (Georges et al., 2007). A study by Pasman et al.
revealed that patients who make a request for PAS before reaching the terminal phase of illness
will be refused, and many of these patients will then no longer discuss their desire for PAS with
their healthcare provider, despite an ongoing wish to die (2013).
Patients in the early stages of Huntington’s disease worried that they would be physically
unable to participate in PAS upon reaching the point in the dying process when they would
desire it. This caused them to wonder when they should formally document their wishes (Regan
et al., 2017). “If I am declining gradually, am I losing the ability to make those decisions? So do
I need to make that decision long before I am symptomatic in order to ensure that I don’t miss
my opportunity? (Regan et al., p. 712, 2017).
Miscommunications.
Like any relationship, good communication creates a positive outcome; conversely,
miscommunications add stress and contribute to negative outcomes. Miscommunications
between patient and healthcare providers about end-of-life wishes are common, often leading to
unintended consequences.
Under-communicating is a form of miscommunicating and leads to a lack of knowledge.
In a study by Silveira, DiPiero, Gerrity, and Feudtner interviewing 728 outpatients at various
outpatient clinics in Oregon, only two-thirds of patients accurately identified that competent
patients in Oregon can legally refuse life-saving or life-sustaining treatment (2000). Knowledge
of end-of-life options was found to be associated with a college education and being Caucasian
(Silveira, DiPiero, Gerrity, & Feudtner, 2000) Experiencing death or illness of a loved one was a
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statistically significant association with better knowledge of end-of-life options. One-third of
participants had authored an advanced directive, but authoring an advanced directive was not a
statistically significant association (Silveira et al., 2000). In this study, patients’ knowledge was
coming from sources other than their healthcare provider or was simply absent.
Miscommunications are common when an explicit request for aid-in-dying is made by
the patient, and the healthcare provider’s response can negatively influence the patient’s
experience. Georges et al. found that 74% of patients found their HCP’s reaction to their request
for euthanasia or PAS to be satisfactory, because they felt like their physician had insight (2007).
However, 16% of patients were disappointed in the HCP’s response to their request, and 10% of
patients were undecided due to the healthcare provider’s ambivalence (Georges et al., 2007).
Pasman et al. explored the patient experience when requests for PAS were refused, with the
reason for refusing being that the patient did not meet the criteria to participate in PAS or
euthanasia (2013). These patients reported still wanting aid-in-dying, even if it was not possible
at that moment; they might not bring it up again if they believe that aid-in-dying was not possible
for their condition or if the provider’s response appeared irrevocable (Pasman et al., 2013). “I’ve
told him several times, and once he said: ‘You mustn’t keep talking to me about euthanasia,
because you know what I can do and what I can’t do, so forget about it’” (Pasman et al, p. 316,
2013). Several of the HCPs in this study were unaware that their patients still wished to die, and
some even admitted to purposefully not bringing up the subject of aid-in-dying with the hope
that the patient would not bring it up either (Pasman et al., 2013). No appointments were made
to evaluate the patient’s situation after the refusal, despite the possibility of the patient’s
condition changing to meet the PAS criteria in the future (Pasman et al., 2013).

Autonomy and Physician-Assisted Suicide

27

A systematic review by Dees et al. found that the factors motivating patients to
participate in euthanasia or physician-assisted suicide varied between the patient and the
physician perspective, with little overlap. The patients reported that their reasons for wanting to
die included “pain, weakness, functional impairment, dependency, being a burden, hopelessness,
indignity, intellectual deterioration, loss of oneself, loss of autonomy, and being tired of life”
(Dees et al., p. 342, 2009). The HCPs pointed to only general weakness, loss of dignity, and pain
as patient motivations for PAS (Dees et al., 2009).

Healthcare providers may lack a clear

understanding of the patient’s desire for PAS.
Stigma of talking about death.
Patients with advanced cancer report difficulties in discussing their impending death,
noting that family and friends avoided the topic (Nissim et al., 2009). Similarly, patients with
Huntington’s disease reported little communication with their loved ones because of a cultural
taboo of death (Regan et al., 2017). This discomfort can even spread to conversations with their
healthcare providers, “It’s the same with family and friends as well as medical professionals. It’s
kind of like people wanting to talk to you about it enough so that you feel heard, but not wishing
to distress you by bringing it up at times when it feels uncomfortable” (Regan et al., p. 713,
2017). These participants felt as though they were left to manage their disease on their own, but
the healthcare provider should be the one to guide the conversation about death (Regan et al.,
2017).
Good communication.
Patients dying from AIDS felt as though they had a good relationship with their HCP
based on feeling like they were treated as a whole person and receiving quality care (Pierson et
al., 2002). According to their relatives, 74% of patients who died by euthanasia or PAS in the
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Netherlands were satisfied by how their HCP handled their request for assisted dying (Georges et
al., 2007).
Patient autonomy.
Having access to PAS allows patients to maintain autonomy and a feeling of control until
the very end of their life (Nissim et al., 2009). Smith et al. found that the patient having control
of his or her surroundings contributed to a better quality of dying (2011). A desire to control
one’s own death was the only psychological motivation for euthanasia or PAS that was shared by
relatives, patients, and healthcare providers (Dees et al., 2010). This includes being involved in
treatment decisions and having the option to cease treatment whenever the patient desires
(Pierson et al., 2002). Patients with Huntington’s disease held the central belief that an
individual has the right to autonomy, and assisted dying is a way of exercising this right (Regan
et al., 2017). A study by Gamondi et al. found that when a loved one’s desire for assisted dying
was not fulfilled, family members felt as though the patient’s right to choose PAS was
disrespected (2019).
Subjectivity.
Suffering is subjective (Dees et al., 2010) as are the patients’ decisions on how and when
to participate in the dying process. “By having the choice to prolong or end suffering when there
is no cure for certain illnesses, we as adult human beings should have the right to decide how
much pain and suffering that we can endure. Only we know that, not the doctors or the state or
the government. We should have that choice” (Pierson et al., p. 593, 2002). Patients in the
early stages of Huntington’s know that the suffering may eventually be too much, but each
patient should be able choose that point for themselves (Regan et al., 2017).
Family experience.
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As mentioned previously, having one’s community present throughout the dying process
is important to many (Pierson et al., 2002). A systematic review of literature by Gamondi et al.
reveals that family members who are involved in their loved one’s dying process have close
bonds with the patient (2019). Playing a role in the patient’s end-of-life care brings comfort to
family members and contributes to family members feeling at peace with the patient’s decision
(Gamondi, Fusi-Schmidhauser, Oriani, Payne, & Preston, 2019). Smith et al. found no
statistically significant differences in connectedness between patients and family in those who
participated in PAS versus patients who did not (2011).
Witnessing the patient’s suffering worsen was a key motivator for families to embrace
the patient’s request for assisted dying (Gamondi et al., 2019). Some patients dying from AIDS
believe that a ‘good’ death would include their families’ acceptance that they were going to die
(Pierson et al., 2002). Patients with Huntington’s disease admit that they would delay dying if
their families were not in agreement (Regan et al., 2017). Gamondi et al. found that few families
experienced regret about the patient’s cause of death when the patient did participate in
euthanasia or PAS, though some family members wished the decision had been postponed
(2019).
A ‘good’ death includes having a sense of resolution, having said good-bye, time to
prepare, and peace with self and others (Pierson et al., 2002). This preparedness represented
positive components for the family’s bereavement and contributed to higher quality preparedness
and symptom control ratings than those who did not die from assisted dying (Gamondi et al.,
2019).
Summary of themes.

Autonomy and Physician-Assisted Suicide

30

As previously stated, significant gaps exist in the literature due to the nature of the topic.
Physician-assisted suicide is limited to the few countries and states where it has been made legal;
thus, the ability to openly study this topic is constrained. The results from the abovementioned
studies are not necessarily generalizable across cultures, religions, or healthcare delivery
systems. Additionally, as noted in the review of literature, suffering at the end-of-life is
subjective, and therefore subject to subject variation cannot be measured. Within subject
variation also cannot be measured, since the subjects are no longer alive following the
intervention. Due to these limitations, studies about physician-assisted suicide are more likely to
be qualitative versus quantitative, as with the research included in this paper.
For patients in the terminal phase of illness, end-of-life suffering is a personal, subjective
experience. Social stigma surrounds the topic of discussing one’s suffering and death; knowing
this, the patient’s healthcare provider bears the responsibility of creating an open conversation
about all end-of-life options with the patient. Physical, emotional, and economic factors
motivate terminally-ill patients to desire to participate in physician-assisted suicide, and the
motivations can vary by diagnosis. Physician-assisted suicide upholds the ethical principle of
autonomy by allowing the patient to choose the timing, location, and context of their own death.
Through avoiding suffering related to the dying process such as entering a persistent vegetative
state, painful lingering, or loss of dignity, PAS contributes to a better quality of life and quality
of death. With physician-assisted suicide as an end-of-life option, patients can die on their own
terms.
Conceptual Framework
When discussing autonomy in Principles of Biomedical Ethics, Beauchamp and Childress
report a misplaced criticism of respect for autonomy taking precedence over all moral
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considerations (2001); others view autonomy as a cardinal moral value that should guide both
politics and healthcare practices (Mackenzie, 2008). Patient autonomy is central to the
conversation about access to physician-assisted suicide as an end-of-life option, and relational
autonomy theory provides a framework for the discussion of the patient experience with PAS in
this paper. In this section, “relational autonomy theory” will be used interchangeably with
“relational autonomy.”
Relational autonomy theory is a rooted feminist theory, “motivated by feminist concerns
about the impacts of oppression and social injustice on women’s (and men’s) opportunities to
lead self-governing lives” (Mackenzie, 2015, p.278), moving beyond the concept of “selfgovernance” found in other theories of autonomy toward analyzing the social, political, and
relational aspects of autonomy. The goal of relational autonomy theory is to build social
relationships and institutions that encourage individuals to lead self-governing lives (Mackenzie,
2015). Four key principles of relational autonomy theory and how it relates to the patient
experience surrounding physician-assisted suicide will be explained in the subsequent
paragraphs.
First, relational autonomy theory states that a person must have a series of self-reflective
skills in order to achieve autonomy competence, “self-control and motivational decisiveness;
emotional skills, such as the capacity to interpret and regulate one’s emotions; imaginative skills,
required for understanding the implications of one’s decisions and envisaging alternative
possible courses of action; and capacities to reflect critically on social norms and values”
(Mackenzie, 2015, p. 286). As explained in the review of literature, in seeking autonomy when
considering physician assisted suicide, the terminally ill patient has been reflective on his or her
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physical and emotional suffering, other courses of action such as simply withdrawing cares, and
social values, for example, avoiding the subject of their own death due to social stigma.
Secondly, relational autonomy theory is particularly relevant to medicine as it
acknowledges a person’s vulnerability and dependence, in contrast to the popular belief that
autonomy equals self-sufficiency (Mackenzie, 2015). This is especially true during the terminal
phase of illness, and the patient’s healthcare provider must recognize the patient’s vulnerable
state. As mentioned in the previous section, the provider’s role in promoting patient autonomy
includes fostering a positive provider-patient relationship, communicating effectively about the
patient’s end-of-life options, and being attentive to the patient’s wishes throughout the course of
their disease.
Thirdly, relational autonomy identifies that autonomous decision-making is sustained
through significant social relationships, and one’s autonomy is not free from social influence
(Mackenzie, 2015). The literature reveals patients’ families embracing the patient’s request for
PAS after witnessing the suffering brought on by the patient’s terminal stage of illness (Gamondi
et al., 2019). These social relationships can also be oppressive to the patient, corroding the
patient’s sense of self-esteem (Mackenzie, 2015), such as patients dying from AIDS needing
their families to accept their death in order for them to consider it a “good” death (Pierson et al.,
2002). The patient’s healthcare provider also becomes a significant social relationship in the
terminal phase of illness. Regan et al. details the patients’ experiences of social stigma
surrounding the conversation about their death, even when talking with their HCPs (2017).
Patients are especially vulnerable to the attitudes and judgments of their HCP, which can aide in
restricting their autonomy (Mackenzie, 2015).
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Finally, relational autonomy considers the impact of societal oppression that restricts a
person’s autonomy. To live an autonomous life, all people from all social groups must have
access to genuine opportunities and a range of options (Mackenzie, 2015). Thus, the social
distribution of autonomy must also be considered, for example, patient populations in some
historically liberal U.S. states have access to physician-assisted suicide while those in other
states do not. Health and social policies have the capacity to both limit and increase patient
autonomy.
Conclusions, Implications, and Recommendations
The purpose of this paper is to explore the patient experience with physician-assisted
suicide to determine if participants in PAS have more control over their end-of-life care. This
section will be organized by stating the author’s conclusions based on the review of literature,
ending with implications for nursing and recommendations.
Conclusions
Though limited to the states and countries where it has been legalized, physician-assisted
suicide is an end-of-life option that allows patients to avoid parts of the physical and emotional
suffering that accompany dying of a terminal illness such as cancer or a neurodegenerative
disease. Terminal illness is life-altering, and PAS contributes to a better quality of life and
quality of death by allowing the patient to die on their own terms: deciding who is present, where
and when their death will take place, and ultimately ending the process of painful and
undignified lingering. Suffering during the terminal phase of illness is subjective; each patient’s
experience will be different, and the patient is the only one who can decide when he or she no
longer wishes to suffer. Healthcare providers play a lead role as a patient advocate by guiding
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both the conversations surrounding the patient’s end-of-life wishes, informing the patient of all
available end-of-life options, and assisting the patient carry out his or her death plan.
Recommendations
Further research should be performed surrounding the patient experience of physicianassisted suicide in the United States and abroad. This research will likely be limited to
qualitative studies, which should delve deeper into the themes found in this paper: patient
motivations for participating in PAS, the influence of the patient-HCP relationship on the
patient’s experience with PAS, and patient autonomy during the dying process. In addition,
other terminal illnesses should be included when studying PAS such as congestive heart failure,
chronic obstructive pulmonary disorder, end-stage renal disease, Parkinson’s disease, or multiple
sclerosis.
Healthcare providers have a responsibility to uphold the patient’s autonomy. Knowing
that the dying experience is subjective, HCPs must adopt the role of student and learn the
patient’s personal definitions of suffering and dying well. Building a trusting relationship with
the patient will assist in identifying terminally ill patients who may be interested in PAS as an
end-of-life option. All treatment options should be discussed frequently throughout the course of
the patient’s illness, and the HCP should encourage the patient to choose the end-of-life option
that best matches the patient’s values and desires. If the HCP does not feel confident with
having EOL discussions, the HCP should either invest in continuing education about all available
EOL options or refer the patient to a different provider.
In keeping with Relational Autonomy Theory and with the patient’s consent, the
healthcare provider should include the patient’s significant social relationships when discussing
end-of-life options with the patient. This will provide a framework for the patient to maintain an
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ongoing dialogue with his or her community and assist the patient’s loved ones in embracing the
patient’s EOL decision. Including these significant relationships will ultimately uphold
autonomous decision making.
In the U.S., physician-assisted suicide is illegal in 41 states as of 2019 (Villenueve,
2019). The majority of American terminally ill patients do not have access to PAS, an option
that has been shown can contribute to better quality end-of-life. Without permission to use
physician-assisted suicide, patients are forced to endure end-of-life processes that are often
drawn out and overwhelmed with suffering; this violates the ethical principle of autonomy: the
patient’s right to request a specific treatment. Thus, physician-assisted suicide should be
legalized in all 50 states, giving every American access to all end-of-life options.
Implications for Nursing
Nurses need to thoroughly analyze their own biases regarding physician-assisted suicide,
educate themselves on the latest information on the subject, and promote open discussions about
physician-assisted suicide amongst their peers. An integrative literature review of American
nurses’ opinions toward PAS found that the majority of nurses in four of the studies supported
PAS primarily due to relieving the patient’s suffering, while nurses in six of the studies were
against PAS primarily for religious and moral issues as well as the potential for the misuse or
abuse of PAS (Pedersen & Tariman, 2017). Nurses who do not support physician-assisted
suicide should not be shamed for their opinions, but this does exhibit the propensity of healthcare
providers to be unsupportive of a treatment based on their own values rather than those of the
patient. The nurses should support their patients whose values differ from their own by referring
patient who are interested in PAS to a different nurse.
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Pedersen and Tariman report that of the six studies finding nurses to be against PAS,
three revealed that nurses might become supportive of PAS if they had more knowledge on the
subject (2017). Educating all nurses by adding curriculum or on the job training about
physician-assisted suicide could garner support from nurses previously opposed to PAS. If
nurses remain unsupportive of physician-assisted suicide, particularly in states that legalize PAS,
significant ethical dilemmas will be present while treating terminally ill patients.
Summary
According to the literature included in this paper, suffering and dying are profoundly
personal experiences. For patients with terminal illnesses such as advanced cancer and
neurodegenerative diseases, physician-assisted suicide is an end-of-life option that allows the
patient to avoid prolonged emotional and physical suffering, thereby contributing to a better
quality end-of-life. Working with patients in this terminal phase, medical professionals such as
healthcare providers and nurses have the unique role of providing end-of-life care, upholding
patient autonomy, and advocating for patients to be granted access to all available end-of-life
options, including the legalization of PAS in all fifty states. Though the concept of physicianassisted suicide can make some healthcare professionals uncomfortable, the legalization of PAS
in several countries and U.S. states makes this issue relevant. The Hippocratic Oath reads,
“Most especially must I tread with care in matters of life and death. If it is given me to save a
life, all thanks. But it may also be within my power to take a life; this awesome responsibility
must be faced with great humbleness and awareness of my own frailty” (Tyson, 2001).
Physician-assisted suicide brings this tension to the forefront of the conversation: When to
preserve life and when to let it go? Based on the research in this paper, only the patient can
answer this question.
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Appendix

REQUEST FOR MEDICATION TO END MY LIFE IN A HUMANE AND DIGNIFIED MANNER
I, ______________________, am an adult of sound mind.
I am suffering from _________, which my attending physician has determined is a
terminal disease and which has been medically confirmed by a consulting physician.
I have been fully informed of my diagnosis, prognosis, the nature of medication to be
prescribed and potential associated risks, the expected result, and the feasible
alternatives, including comfort care, hospice care and pain control.
I request that my attending physician prescribe medication that will end my life in a
humane and dignified manner.
INITIAL ONE:
______ I have informed my family of my decision and taken their opinions into
consideration.
______ I have decided not to inform my family of my decision. ______ I have no family
to inform of my decision.
I understand that I have the right to rescind this request at any time.
I understand the full import of this request and I expect to die when I take the
medication to be prescribed. I further understand that although most deaths occur
within three hours, my death may take longer and my physician has counseled me
about this possibility.
I make this request voluntarily and without reservation, and I accept full moral
responsibility for my actions.
Signed: _______________ Dated: _______________
DECLARATION OF WITNESSES
We declare that the person signing this request:
(a) Is personally known to us or has provided proof of identity;
(b) Signed this request in our presence;
(c) Appears to be of sound mind and not under duress, fraud or undue influence; (d) Is
not a patient for whom either of us is attending physician. ______________Witness
1/Date
______________Witness 2/Date
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NOTE: One witness shall not be a relative (by blood, marriage or adoption) of the
person signing this request, shall not be entitled to any portion of the person’s estate
upon death and shall not own, operate or be employed at a health care facility where
the person is a patient or resident. If the patient is an inpatient at a health care facility,
one of the witnesses shall be an individual designated by the facility.
(Oregon Death with Dignity Act, 1994)
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Table 1
Database Search
Date of
Keywords Used
Search
09.01.19 Patient experience
09.01.19 Physician assisted suicide
09.01.19 “Patient experience” AND “physician
assisted suicide”
09.11.19 Quality of life
09.11.19 Quality of death
09.11.19 “quality of life” AND “quality of death”
AND “physician assisted suicide”
09.24.19 Physician assisted suicide
09.24.19 Emanuel, Ezekiel AND physician
assisted suicide
09.24.19 Ganzani AND Silveira

Database/Source
# of Hits
Used
Listed Reviewed Used
CINAHL/Ebsco 127,984
CINAHL/Ebsco 2,897
CINAHL/Ebsco
131
16
5
CINAHL/Ebsco 173,424
CINAHL/Ebsco 14,895
CINAHL/Ebsco
59
The Cochrane
Library
Incremental
search of
references
Incremental
search of
references

15

5

2

2

1

16

3

1

1

1

1
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Literature Table
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Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications/
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1

Dees, M.,
Vernooji-Dassen,
M., Dekkers, W.,
& van Weel, C.
(2010).
Unbearable
suffering of
patients with a
request for
euthanasia or
physician-assisted
suicide: An
integrative review.
Psycho-Oncology,
19, 339-352. doi:
10.1002/pon.1612

To provide a
systematic
overview of
descriptions of
unbearable
suffering and
current views on
suffering of
patients in the
context of a
request for EAS
(euthanasia or
physicianassisted suicide)
as suffering is a
requirement of
due care and
difficult to assess

*Patients who
request EAS
*Literature from
January 1, 1980June 30, 2007
*Literature search
in English, Dutch,
and Flemish of the
databases PubMed,
Embase, Cinahl,
Web of Science,
Psych Info, and the
Royal Dutch
Medical
Association

*Concept analysis
of an integrative
review
*All included
literature had a
description of
suffering of
patients with an
actual request for
EAS or a
definition of
suffering was
included
*Two authors
independently the
full text articles
*Articles were
categorized by
who reported the
patient suffering,
i.e.: patients,
HCPs, or family
*A third and
fourth researcher
helped analyze the
qualitative data

*Every study referred to
suffering or “unbearable
suffering” but no
generally accepted
definition
*Four themes of
suffering emerged:
physical, psychological,
existential, or spiritual,
which all contributed
equal numbers of
motivations
*Suffering in the context
of dying is generated by
factors undermining the
quality of life
*Themes in qualitative
suffering: Caused by:
pain, weakness,
functional impairment,
dependency, being a
burden, hopelessness,
indignity, intellectual
deterioration, loss of
autonomy, tired of life
*Motivations for EAS
differed between the
patients, physicians, and
family
*Pt motivations: pain,
Weakness, dependence
on others, humiliation

*Suffering is
subjective to
each person
*All forms of
suffering are
potentially
unique to the
death experience
versus other
experiences that
may cause
suffering
*Important for
HCPs to bring up
the conversation
of suffering with
the patient,
because the
motivations that
lead people to
request EAS are
complex
*Research on the
patient
experience
requesting EAS
is limited to
countries where
it is legal;
“illegal”
motivations may
be missing

*Individual patient
perspective is the
most important
*Suffering involves
the patient as a
whole
*Patients must be
involved in
suffering in order
to meet criteria for
PAS by physicians
in Oregon and the
Netherlands, yet it
cannot really be
measured
*Motivations
differed between
the patients/
families/HCPs, but
the patient’s
motivations should
be the most
important
*EAS being
legal/illegal is
complicating the
ability to research
what is best for
end-of-life care

V

*55 articles were
included
*20 articles with
definitions of
suffering of
patients, 35
empirical studies
about suffering of
patients with a
request for EAS
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Evidence

2

Emanuel, E.,
Fairclough, D.,
Slutsman, J. &
Emanuel, L.
(2000).
Understanding
economic and
other burdens of
terminal illness:
The experience of
patients and their
caregivers. Annals
of Internal
Medicine, 132(6),
451-459.

To determine the
cause of
economic and
other burdens in
terminally ill
patients and
identify possible
interventions

*Terminally ill
patients (N=988)
without HIV/AIDS
with <6mos. to live,
able to sign
consent, and spoke
English as well as
their primary
caregiver (N=893)
*Six different
locations were
randomly selected
across the USA
based on
metropolitan
statistical areas:
Worcester, MA; St.
Louis, MO;
Tucson, AZ;
Birmingham, AL;
and Brooklyn, NY.
One rural setting as
well: Mesa County,
CO.
*Physicians in
those areas were
randomly selected
and asked to
identify patients

*In-person
interviews of
patients and their
caregivers
*Survey was
developed
following a lit.
search, pilot study,
focus groups, and
expert
consultation,
contained 135
questions,
caregiver survey
contained 118
questions adapted
from seven
different survey
instruments
*Measured social
supports,
communication
with HCPs,
personal and
spiritual meaning,
care needs, EOL
care plans,
economic burdens,
euthanasia, and
PAS
*Patient care
needs ranked
“low” to “high” on
a four point scale

*Mean age: 66.5, leading
cause of terminal illness:
cancer (51.8%), heart
disease (18%), and
COPD (10.9%)
*Pt’s with moderate or
high care needs were
significantly more likely
than those with low care
needs to report the cost
of their illness was a
moderate or great
economic hardship
(44.9% compared with
35.3%, p=0.005), that
10% of their household
income was spent on
healthcare costs other
than insurance premiums
(28% compared to 17%,
p<0.001), and that they
had to sell assets, take
out a loan or mortgage,
or obtain an additional
job (16.3% compared to
10.2%, p=0.004)
*In patients requiring
substantial assistance,
14.9% had seriously
thought about or
discussed PAS compared
to 8.2% of patients with
few care needs, p=0.001

*Terminally-ill
patients in the
USA with
substantial care
needs experience
significant
economic and
other burdens
*Best to create
interventions that
help with
patients’ needs
but do not add
cost
*Important to
take cost into
consideration
when treating
terminally ill
patients
*HCPs need to
talk with patients
AND families
about cost
*Sample may be
biased;
physicians may
have selectively
referred patients
*21% of referred
patients died or
became
incapacitated

*Cost of terminal
illness is more than
emotional
*Terminal illness
takes a toll on the
entire family,
particularly the
financial health of
the family
*Sad that families
have to take out
additional
loans/mortgages or
get other jobs just
to pay for the care
of their loved one
instead of spending
time with the
terminally ill
*Study takes place
in the USA
*Difficult to obtain
data on this topic
d/t the patients
dying or being
mentally unable to
participate
*With PAS being
illegal in most
states, is the family
unduly forced to
carry a heavier
economic burden?
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Evidence

3

Gamondi, C.,
FusiSchmidhauser, T.,
Oriani, A., Payne,
S., & Preston, N.
(2019). Family
members’
experiences of
assisted dying: A
systematic
literature review
with thematic
synthesis.
Palliative
Medicine, 1-15.
doi:
10.1177/02692163
19857630

To offer an
understanding of
the experiences
of family
members of
patients who died
using assisted
dying in
jurisdictions
where it is legal

*Direct family
members of
patients who
participated in
euthanasia or PAS,
over the age of 18

*Primary research.
Quantitative and
qualitative
*Thematic
synthesis using the
Preferred
Reporting Items
for Systematic
Reviews and
Meta-analysis
Protocol
guidelines
*Articles screened
in two phases by
three reviewers
*Quality appraised
using structured
checklist with
higher scores
indicating better
quality
*Three step
process: articles
were coded
inductively,
descriptive themes
were developed,
and then analytical
themes were
generated

*Family members
involved in assisted
dying had strong, open,
positive, and supportive
relationships with the pt.
*Family members
occasionally excluded
members who opposed
assisted dying
*Witnessing the patient
suffer motivated family
members to agree with
the pt’s request
*Family members who
shared the values of the
patient saw the decision
as the patient’s right
*Positive emotions were
experienced such as
being at peace, accepting
the patient’s choice, and
having felt included
*Few experienced regret
*Family members
perceived a fast decisionmaking pace as being
problematic
*Some wished it had
been postponed
*Death rituals were
intentional and planned
*Family thought assisted
dying contributed to the
pt’s QOL

*Families can be
very involved in
supporting pts
interested in PAS
*PAS could aide
in promoting
QOL/QOD
*Assisted dying
may challenge
family value
systems
*Conversation
with family
members may be
more open in
countries where
assisted dying is
legal
*Family
members are
important patient
advocates during
the dying process
*Western
countries only;
other
cultures/religions
may have
different
experiences
*Proxy
perspective vs
patient
perspective

*PAS has the
potential to
increase
QOL/QOD under
the right
circumstances
*Patient suffering
as a reason to
participate in PAS
*What about the
family members
who felt
uncomfortable with
assisted dying?
Potentially divisive
*Family members
are potentially
taking on legal
risks if they are
actively involved
in the patient’s
EOL plan; legal
protections should
be in place for
family members
*Family members
are important
players in the pt
death experience
and should also
have their needs
met such as
counseling services

V

*Countries where
assisted dying is
legal: Netherlands,
Canada,
Switzerland, and
USA (Oregon,
Washington,
Vermont only)
*Articles from Jan
1992-Feb 2019
*Databases used:
Medline, Embase,
CINAHL, AMED,
PsychINFO
*N=19, 11 articles
were qualitative,
and 8 were
quantitative
*Patients primarily
had cancer or ALS
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4

Ganzini, L.,
Silveira, M., &
Johnston, W.
(2002). Predictors
and correlates of
interest in assisted
suicide in the final
month of life
among ALS
patients in Oregon
and Washington.
Journal of Pain
and Symptom
Management,
17(3), 312-317.

To understand
more about ALS
patients’ interest
in physicianassisted suicide
throughout the
terminal phase of
their illness,
particularly the
final month of
life

*Terminally ill
patients with ALS
*N=50 family
caregivers of
patients with a
confirmed
diagnosis of ALS
from Oregon and
Washington who
had died between
1995-1999
*Patients cared for
in the Oregon
Health Sciences
University
neuromuscular
clinic or Portland
Veterans Affairs
Medical Clinic or
had participated in
a previous study
(N=38)
*Convenience
sample

*Descriptive
*Caregivers were
recruited by mail
*Surveyed in
person or over the
phone
*An interview
(median of 11
months between
patients’ death and
interview), and a
survey (median of
36 months
between pt death
and survey)
*Results from
caregivers
compared to pt
results from
previous study
*Caregivers rated
suffering on a 6
point scale
measuring pain,
suffering, anxiety,
depressed mood,
dyspnea,
confusion,
insomnia, choking
episodes,
difficulty
communicating
*Questioned about
interest in PAS

*Caregiver knew patient
for median of 34 years
*16 (32%) explicitly
discussed wanting PAS
in the last month of life
*Patients who requested
PAS had frequent
insomnia (p=0.003), pain
(p=0.01), severe
discomfort (p=0.03), and
distress at being a burden
(p=0.02)
*No difference between
those who did and did
not want assisted suicide
in the last month of life
in prevalence of
depression
*The patient having
indicated interest in
assisted suicide in the
previous study (OR:
11.7, 95% CI: 1.1-130.7)
and a hopelessness score
of >9 on the Beck
Hopelessness Scale (OR:
12.5 (1.9-83.2) were
predictors of pt
continuing to request
PAS
*50% of patients initially
interested in PAS had a
persistent interest
throughout the illness

*Patients
interested in PAS
in the final
month of life
may be identified
earlier
*HCPs should
screen for
hopelessness in
patients with
ALS
*Interest in PAS
persists over
time; important
to continue to
reassess
*Controlling
pain and
sleeplessness
may help the pt
avoid wanting
assisted dying
*Small sample
size,
convenience
sample
*More research
before death (on
patients) and
after death (on
those pts family)
should be
performed)

*Death with
Dignity Act was
enacted in 1997;
thus only four
patients were
eligible for PAS
*Open
communication
between pt and
provider about
EOL desires is
profoundly
important; should
drive terminal
illness management
*Symptom
management can
drive patient
emotional state
*Newly legal in
both states at the
time of the study;
what about
recently?
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5

Georges, J.,
OnwuteakaPhilipsen, B.,
Muller, M., Van
der Wal, G., Van
der Heide, A., &
Van der Maas, P.
(2007). Relatives’
perspective on the
terminally ill
patients who died
after euthanasia or
physician-assisted
suicide: A
retrospective
cross-sectional
interview study in
the Netherlands.
Death Studies, 31,
1-15. doi:
10.1080/07481180
600985041

Gain
understanding of
the background
and history of
patient requests
for EAS and the
significance of
EAS on the
patient’s EOL

*Studying patients
who used EAS to
end their lives

*Descriptive,
cross sectional

*85% had cancer, 15%
had other diseases,
mostly neurologic such
as ALS
*79% of pts had voiced
their wishes prior to
being terminally ill
*67% of wishes directed
at unbearable suffering
and heavy dependence on
others
*84%: explicit requests
made w/in 3 mos. of
death
*74% satisfied with how
the physician dealt with
the request
*Patients <68yrs were
concerned about missing
an important life event
(p=0.031)
*92% of relatives
believed EAS
contributed to the
patient’s quality of the
end-of-life by avoiding
further suffering (37%),
respecting the pt’s wish
(29%), dignity would be
preserved (18%), ending
current suffering (16%)
*23% thought EAS came
too late, causing more
pain/suffering

*Close relatives
of the dying
patient should be
part of the care
plan
*Patients may
have EOL
wishes before
becoming
terminally ill
*Discuss
patient’s
personal
definitions of
dignity and being
burdensome
*Ask patient
about possible
life events that
they want to
attend
*Taking time to
sort through the
patient’s request
may prolong pt
suffering
*Retrospective
study, also only
getting the
perspective of
pt’s proxies,
could be biased
or withholding
information

*Explore possible
alternatives to
relieve suffering
and pts feeling like
a burden; they may
not even feel like
they need PAS if
their motivations
for participating
are relieved
*Proxy relations
are part of the
patient, when
thinking about or
planning the
patient’s dying
process; must build
positive
relationships with
relatives.
*Illegality of PAS
may be
unnecessarily
prolonging
suffering in certain
patients
*Thinking about
EAS is different
than making an
explicit request
*EAS is respecting
the patient’s wishes
and feeling in
control

VI

*Interviewed most
involved relative of
patient
*Nationwide,
across the
Netherlands
*N=87
*October 2001January 2002
*Mean period of
time between the
patient death and
interview: 17.6
months
*Interviewed in
their home

*Random
sampling of 167
physicians with
patients who used
EAS approached
patients’ family
members
*Interviews were
2 hours long
*Semi-structured
interview focused
on pt’s illness,
motivations for
EAS, end of the
pt’s life, and the
dying process
*Multiple
interviewers,
trained
specifically to
participate in
study
*Descriptive
statistical analysis
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Johansen, S.,
Hølen, J., Kaasa,
S., Loge, J., &
Materstvedt, L.
(2005).Attitudes
towards, and
wishes for,
euthanasia in
advanced cancer
patients at a
palliative
medicine unit.
Palliative
Medicine, 19, 454460.

To explore and
describe attitudes
and wishes for
euthanasia/PAS
in a group of
patients with
advanced cancer
on a palliative
unit

*Patients with
advanced, terminal
cancers: lung (n=2),
prostate (n=5), GI
(n=5), breast (n=2),
head/neck (n=2),
and unknown
primary cancer
(n=2). Total:
N=18, cognitively
intact
*Estimated life
expectancy: <9
mos. per MD
*Convenience
sample on the
Palliative Medicine
Unit, Department
of Oncology and
Radiotherapy,
University Hospital
of Trondheim,
Norway
*Survival from
time of interview: 3
days – 9 mos.

*Qualitative
*Research RN
used interview
guide with 8
issues + sub
questions
*RN did not work
at the hospital
*One, 45 minute
face to face
interview
*Euthanasia/PAS
defined to patients
prior to interview
*Interviews were
recorded and
transcribed
*Interpreted
according to
grounded theory
*Analyzed by
pooling concepts,
inter-case analysis
to compare
interviews, and
central concepts
were grouped
*Two
investigators
reviewed and
interpreted all
transcripts with
few divergences

*Positive attitude toward
Euthanasia/PAS: Fear of
future pain and/or poor
quality of life; right to
choose when suffering
should end
*Negative attitude:
Religious and ethical
arguments such as the
wrongdoing of taking life
*Possibility of wishing
for euthanasia/PAS; none
of the patients wished for
euthanasia/PAS at the
time of the interview,
always future oriented
*Factors influencing
wishes for
euthanasia/PAS: Fear of
future pain, worries
about future poor QOL,
worries about future lack
of hope
*Experiences of previous
pain caused fear of future
pain attacks in the future
*Will to live decreased
with unbearable pain;
wish to die disappeared
with pain alleviation
*Most patients expressed
hope for the future, such
as attending a family
event

*Controlling
patients’ pain
throughout the
course of their
illness may
influence
whether they
desire
euthanasia/PAS
*Pain is an
indicator of QOL
if cancer patients
*More research
on the patient
perspective/
experience
should be
performed
*Only one
interview that
was relatively
short
*Validity may be
limited due to
the variability in
survival time
after the
interview
*Euthanasia/PAS
is illegal in
Norway; patients
may not have
answered
honestly

*Cancer is very
painful; much
different
motivation than
patients with
neurologic terminal
illnesses such as
ALS
*Wishes for
euthanasia/PAS
fluctuate
*Difficult to
research the
terminally ill
cancer patient
because there is not
a universal timeline
or course of disease
*Whether or not
PAS/Euthanasia is
legal in the study’s
country could
influence results
*Hope for the
future influences
the decision to
desire to participate
in PAS; can hope
be cultivated?
*A wish for PAS is
different than a
request for PAS,
could be
ambivalent

VI
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7

Maessen, M.,
Veldink, J.H.,
OnwuteakaPhilipsen, BD., de
Vries, J., van der
Wal, G., & van
den Berg, L.
(2009). Trends
and determinants
of end-of-life
practices in ALS
in the Netherlands.
Neurology, 73,
954-961.

To determine
which factors
influence end-oflife practices in
patients with
ALS and whether
rates of this
population using
euthanasia or
PAS are
changing over
time

*Patients with a
possible, probable,
or definite
diagnosis of
amyotrophic lateral
sclerosis (ALS)

*Cohort study
*Questionnaire
was sent to the
patients’ physician
and informal
caregiver
*Physician
questionnaire:
need for
interdisciplinary
consultation,
palliative care,
patient depression
*Informal
caregiver
questionnaire:
patient’s social
structure, feelings,
religion,
depression using
DSM-IV, feelings
of hopelessness
*Data was
compared to the
questionnaire
results from a
study from 19941998
*Other EOL
practices
mentioned:
withdrawing/with
holding treatment

*35 (16.8%) patients
participated in
euthanasia/PAS from
2000-2005, not a
significant change
previous data
*PAS/EAD patients had
higher level of education
(p=0.03), did not think
religion was important
(p=0.04)
*No association between
PAD/EAD and
depression
*No significant
differences between
quality of care for
patients with PAS/EAD
and other patients
*Reasons reported by
informal caregivers for
PAS/EAD: fear of
choking, no chance of
improvement, loss of
dignity, dependence on
others, fatigue.
Infrequently mentioned:
pain, feeling like a
burden
*PAS/EAD: More likely
to die at home (p=0.007)
vs hospice /nursing home
*All deaths considered
peaceful by physician

*Numbers of
patients
participating in
PAS/EAD did
not increase (not
a slippery slope)
*Patients were
able to be at
home
*All deaths were
peaceful:
important
implication when
HCPs are talking
with patients
approaching
EOL

*Patient
motivations for
PAS seem to be
consistent; perhaps
pain wasn’t an
issue because it
was ALS versus
cancer or other
terminal diagnoses
*Interesting that
there was not a
relationship
between depression
and hastening
death
*Dying at home
versus going into a
SNF: might also be
specific to ALS
*Unable to ask the
patient how his/her
experience was;
data is limited to
patient proxies

IV

*University
Medical Center of
Utrecht,
Netherlands, a
national referral
center for ALS
patients
*Patients who died
between January
2000 – June 2005
*Involved patient’s
physician (N=204)
and informal
caregiver (N=209)
for 209 individual
patients

*Euthanasia and
PAS were
combined;
unclear how
many patients
participated in
PAS
*Data is posthumous and
from the
physician/
informal
caregiver, not the
patient.
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8

Nissim, R.,
Gagliese, L, &
Rodin, G. (2009).
The desire for
hastened death in
individuals with
advanced cancer:
A longitudinal
qualitative study.
Social Science and
Medicine, 69, 165171. doi:
10.1016/j.socscim
ed.2009.04.21

To contribute to
the understanding
of the desire for
hastened death
(DHD) in
patients with
advanced cancer

*Patients with
Stage III or IV lung
or Stage IV GI
cancer, >18 years
old, no cognitive
impairment

*Qualitative,
longitudinal
design
*Grounded theory
method
*Baseline scale
Schedule of
Attitudes Toward
Hastened Death
*Semi-structured,
discovery-oriented
interviews
*Most interviewed
at least twice
(Range: 1-6),
follow-up
interviews were
every 2-4 months
during illness
stability
*Interviews
audiotaped and
transcribed
*Analyzed by a
nursing doctoral
student using the
“hermeneutic
circle,” and
broken down into
“meaning units”
*Findings
discussed
biweekly with
team members

*Mean age: 61
*19 participants died
during study; mean final
interview timeline: 3
months before death
Three categories:
*DHD as a hypothetical
exit plan: Common and
persistent (89% pts),
future plan when all else
had failed, provided
reassurance of autonomy
until the end, enhanced
ability to tolerate present,
9 patients wished PAS
were legal and is morally
justifiable to relieve
suffering, rarely
discussed with others
*DHD as an expression
of despair: Pts feel
emotionally trapped in
despair and hopelessness,
experienced by all pts but
transient, for a few days.
Often triggered by pain
*DHD as letting go:
Emerged in final weeks,
recognition that death is
imminent, welcomed,
refused treatments,
reached “limit”, difficult
to discuss dying with
family and friends

*Being able to
hasten death
allows patients to
feel in control in
all stages of
terminal illness,
not just at the
end
*DHD is natural,
not a crisis
*HCPs need to
discuss EOL
options with
patients,
regardless of
legal access to
PAS
*Controlling pts
symptoms,
particularly pain,
could help them
avoid feelings of
despair/hopeless
ness
*Treatments
interfere with
final stage of
dying
*Only one
interviewer who
also analyzed
tapes; results
could be biased

*Access to PAS
helps patients bear
current suffering,
PAS being legal
may enhance QOL
in the present, even
if pts do not
participate in PAS
*PAS being illegal
prolongs suffering
and limits pt
autonomy
*Nonmaleficence
is potentially being
violated by forcing
patients to suffer
who wish to hasten
their death
*Rare to have data
about the patient
experience in the
final stage of
illness
*Not talking about
death with HCPs or
family/friends is a
common theme
*Talking about
death options,
including PAS,
may give the pt
“permission” to
talk about EOL
preferences

VI

*Patients were
recruited from a
large cancer center
in Toronto, Ontario,
Canada
*Patients were
already
participating in a
quantitative study
measuring DHD
*N=27, 20 with GI
and 7 with lung
cancer
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9

Pasma, H.,
Willems, D., &
OnwuteakaPhilipsen, B.
(2013). What
happens after a
request for
euthanasia is
refused?
Qualitative
interviews with
patients, relatives,
and physicians.
Patient Education
and Counseling,
92, 313-318.

To obtain indepth
information from
both patient and
physician about
the situation
when EAS is
refused

*Patients who had
been refused EAS
or a relative of a
patient who had
been refused and
died prior to study

*Qualitative,
cohort study,
explorative
*Random
sampling from an
advanced directive
database received
a questionnaire
asking if the
patient (or relative
of a decedent) had
been refused EAS
in the last 3 years
*Single interview,
patient: 60-120
min., MD: 30-60
min
*Topic list:
Reason for refusal,
physician-patient
communication,
situation after
refusal; physicianspecific: attitude
toward EAS
*All interviews
recorded and
transcribed, used
open coding,
organized using
inductive coding;
two researchers
were involved in
coding

*None of the pts were in
disease terminal phase
*All MDs had >5 years
of experience, most had
performed EAS

*HCPs must
follow legal
criteria before
approving EAS
(+PAS)

VI

*MDs all denied request
because lawful criteria
had not been met; 6/11
had doubts that the pt’s
suffering was unbearable,
5/11 thought there were
treatment alternatives,
3/11, thought pt was not
sincere because the pt
only mentioned it once

*Must keep the
conversation
open and
continue to
discuss EOL
options and
patients’ wishes
to die

*Suffering is
subjective and
unmeasurable, yet
a HCP is supposed
to measure it to
fulfill the legal
criteria? This
seems unfair to
both patients and
physicians.

*N = 12, 3 of these
were relatives of a
patient who had
died after being
refused,
interviewed in their
home
*10 people
consented to their
physician being
interviewed (N=11;
one patient had two
physicians),
interviewed in their
office
*EAS refused
>6mo prior to
interview
*Netherlands, Dec.
2005-Sept 2007

*All 9 pts and 3 relatives:
wish to die remained
after being denied, even
after alt. treatments; most
thought no longer an
option after being refused
*None decided to switch
physicians after being
refused
*Several cases, the MD
had a different
perspective than the pt
about patient’s wishes

*A pt no longer
mentioning their
wish to die does
not mean that it
does not exist
*HCP’s role to
initiate
conversation
about EOL/death
*Euthanasia, not
PAS
*Only one
interview session

*Miscommunications
between pts and
MD about EOL
care are common
and can have
serious outcomes
*Talking about
death with patients
may open up
conversations
about specific EOL
options
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10

Pierson, C., Curtis,
J., & Patrick, D.
(2002). A good
death: A
qualitative study
of patients with
advanced AIDS.
AIDS Care, 14(5),
587-598. doi:
10.1080/09540120
21000005416

To understand
and determine
what patients
with advanced
AIDS would
consider a “bad”
or “good” death

Patients diagnosed
with an AIDSdefining illness and
a CD4 count
<100cells/ml,
English speaking,
no diagnosis of
dementia

Qualitative

*15 domains were
identified as defining a
“good”/”bad” death
*The most mentioned
domain influencing a
“good death” was
symptom control;
absence of pain was the
most stated concern, and
degree of pain correlated
with a death being
labeled as “bad”
*The second domain was
“quality of life,”
specifically avoiding a
prolonged dying
experience, fear of
becoming a “vegetable”
or living on machines
*PAS was the tenth most
common domain
contributing to a good
death, with several
patients stating that PAS
would ensure the “good”
death that they desired
and escape unbearable
pain

*Important to
discuss the
patient’s end-oflife perspective,
philosophies, and
wishes with their
provider as each
patient
perspective is
different

*The death
experience is
subjective; each
patient may have
different priorities

VI

CINAHL/Ebsco
World Host

N = 35
Convenience
sample; recruited
through
advertisements at
university and
community clinics
in the state of
Washington, USA
Sample size was
decided when no
new themes
emerged

Analyzed based
on grounded
theory
Face to face
interview in a
quiet setting with
only the
interviewer and
the patient present
All interviews
were audiotaped
and transcribed,
open and selective
coding was used
to identify themes
and domains
Two investigators
independently
reviewed and
coded the
transcripts;
discrepancies were
discussed, and a
third investigator
acted as an
arbitrator if an
agreement could
not be reached

*PAS may play
an important role
in creating a
good quality
death
*Interview
lacked structure
by only asking
two open-ended
questions
*Patients were
only interviewed
once
*Unclear which
stage of the
dying process
each patient was
in

*The provider
plays an important
role in drawing out
the patient’s
wishes, particularly
discussing patient’s
fears and concerns
*Patient
perspective could
change, depending
on the stage of
death
*Nice that the
interview focused
on practical details
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11

Regan, L, Preston,
N., Eccles, F., &
Simpson, J.
(2017). The views
of adults with
Huntington’s
disease on assisted
dying: A
qualitative
exploration.
Palliative
Medicine, 32(4),
708-715. doi:
10.1177/02692163
17741850

To explore the
perspective of
people who live
with the
inevitability of
developing
Huntington’s
disease, on
assisted dying

*People who had a
diagnosis of
Huntington’s
disease or tested
positive for the
mutant gene

*Qualitative,
exploratory
research
*Individual semistructured
interviews
following an
interview schedule
*Recruited via
advertisements on
social
media/charity
events
*Single interview,
median length: 47
minutes. 5 via
telephone and 2
in-person
interviews
*Interviews were
recorded an
transcribed, then
analyzed in five
steps:
familiarizing self
with data,
generating initial
codes, searching
for themes,
reviewing themes,
defining themes

Four identified themes:
1) Autonomy: Assisted
dying as a way to take
control as well as an act
of kindness. A point
would be reached when
life would no longer be
meaningful, each person
should choose that point
for themselves
2) Huntington’s disease
emphasizes death:
Suffering was more
about loss of self than
pain; many witnessed
their relatives die from
Huntington’s, which
influenced views on PAS
3) Dilemmas in decisionmaking: No cure for
Huntington’s; PAS is an
imperfect solution. Might
be too physically/
congnitively impaired to
participate in PAS.
Illegal in Britain, so
would have to be well
enough to travel
4) Absence of explicit
conversation about death:
Difficult topic of
conversation, often
avoided with family and
HCPs, feel lonely

*HCPs should
talk honestly
about pt’s
thoughts and
feelings r/t death
from the very
beginning of a
diagnosis such as
Huntington’s;
the patient is
already thinking
about it. Patients
may otherwise
not know EOL
options
*Patients have to
be physically
able to
participate in
PAS but might
not be
emotionally
ready
*Early in the
disease process,
not terminally ill;
views may
change as
disease
progresses
*Patients selfselected to
participate

*Patient autonomy
*Many excellent
patient quotes
*Point at which life
is not meaningful is
subjective
*Suffering was less
about pain and
more about loss of
self; similar to ALS
study
*PAS is not a
solution or a cure,
just a way to ease
suffering
*Huntington’s
disease process is
long and drawn
out; likely will not
qualify as
terminally ill (<6
mo), likely would
not qualify for PAS
(unable to
physically/mentally
meet criteria once
they are deemed
terminally ill)
*Illegal in many
states, thus forcing
people to have to
be well-enough to
relocate

VI

Cinahl/Ebsco

*N=7; 5 women, 2
men
*Median age: 35
years, presymptomatic or in
the early stage of
the disease
*Great Britain

DEATH WITH DIGNITY?

56

No.

Citation /
Search Engine
Used

Purpose/
Objectives

Study population/
Sample/
Setting

Study Design/
Methods/
Major Variables/
Instruments and
Measures

Result(s)/
Main Findings

Implications/
critique

Themes/
Comments

Level of
Evidence

12

Silveira, M.,
DiPiero, A.,
Gerrity, M., &
Feudtner, C.
(2000). Patients’
knowledge of
options at the endof-life. Journal of
the American
Medical
Association,
284(19), 24832488.

Estimate the
percentage of
outpatients who
are aware of 4
areas related to
end-of-life care:
refusal and
withdrawal of
life-saving
treatments,
physiciansassisted suicide,
active euthanasia,
and the doctrine
of double effect

*Outpatients going
to a routine clinic
appointment

*Cross sectional
survey
*Selfadministered
survey, sixthgrade reading
level, written by
researcher and
pilot-tested prior
to study
*Pts were invited
to participate
independently
during check-in
with PCP
*Questionnaire
presented vignette
of a hypothetical
patient who dies
from cancer
*Assesses pt
experience with
EOL dilemmas
and experience of
personal illness,
writing an
advanced
directive,
experiencing death
or terminal illness
of a loved one,
and participating
in proxy decisionmaking

*69% understood that
competent pts can refuse
treatment
*46% identified that pts
can legally withdraw care
*23% identified PAS as
an option in Oregon for
competent pts with
terminal illness
*32% reported that
euthanasia was illegal
*41% recognized double
effect as legal (giving
pain meds knowing that
it could end the patient’s
life)
*64% of respondents
who knew PAS was legal
also thought that
euthanasia was legal
*89% thought survey
was clearly worded
*63% were confident in
their responses;
confidence was
associated with
experience of death of
loved ones (p<0.01)
*Personal experience
with illness and
authoring an advanced
directive were not
significantly associated
with better knowledge

*Misunderstandi
ng of EOL
options;
important to
discuss with pts,
regardless of
disease,
particularly
option to
withdraw lifesustaining care
and the
differences
between PAS
and euthanasia
*Going through
EOL cares with a
family member
is one of the
main ways to
learn about it

*Survey conducted
after the 1997
referendum
confirming the
Death with Dignity
Act; even with all
of the public
discussion
surrounding PAS,
pts still lacked
knowledge about
EOL options
*Many options
shows that EOL is
a complex legal,
medical, and
ethical issue;
important to
discuss with HCPs
*How to best
educate the public
about EOL
options?
*Should not be the
case that people are
more educated
about EOL only
because they
witnessed their
family member’s
experience

VI

*English-speaking,
>18 years old
*N=728
*4 primary care
sites around the
state of Oregon,
USA: Internal
Medicine Clinic at
Oregon Health
Sciences
University,
Portland; 3 family
practice/internal
medicine clinics in
Beaverton,
Sellwood, and
Tigard, Oregon
*May and June
1999

*Possible
selection bias
(survey)
*No information
on nonresponders
*Only surveyed
outpatients in
Oregon; results
may not be
generalizable
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Smith, K., Goy,
E., Harvath, T., &
Ganzani, L.
(2011). Quality of
death and dying in
patients who
request physicianassisted death.
Journal of
Palliative
Medicine, 14(4),
445-450. doi:
10.1089/jpm.2010.
0425

To determine if
there was a
difference in the
quality of the
dying experience
using the
perspective of
family members
of patients who
participated in
physicianassisted suicide,
requested PAS
but did not
receive a lethal
prescription, and
patients who did
not participate in
PAS

*Family members
of terminally ill
patients who
participated in PAS
(N=52), patients
who requested but
did not receive PAS
(N=32), and
patients who did
not partake in PAS
(N=63)
*Convenience
sample; recruited in
NW Oregon from 2
medical centers, 3
hospices, the
Amyotrophic
Lateral Sclerosis
Association of
Oregon, and
Compassion for
Choices of Oregon
*2004-2007

*Cross-sectional
survey
*Used a validated
instrument:
Quality of Death
and Dying, a
retrospective 33item survey
measuring the
time period
immediately
preceding the
death (7 days if
responsive, 30
days if
unresponsive),
from the family
members’
perspective
*Assessed
symptom control,
social
connectedness,
preparation for
death, and
transcendence

*PAS patients had more
control over their
surroundings and ability
to feed self than the other
two groups (p <0.01) and
control of bladder/bowel
and energy than the
group who requested but
did not receive PAS
(p<0.05)
*No significant items in
the connectedness +
transcendence domains
*Those who received a
prescription were more
likely to say good-bye to
loved ones (p = 0.003)
and less likely to engage
in a spiritual ceremony (p
= 0.002) than those who
did not pursue PAS
*No significant
differences between
groups were found in
family member’s
perception of overall
quality of life in the week
before death
*Family members rated
the quality of the
moment of death higher
in PAS patients (p
<0.001)

*Better quality
of death in PAS
patients d/t
avoiding
physical
symptoms and
being able to
prepare for death
*By preparing,
PAS patients are
able to say goodbye to loved
ones
*PAS allows for
a potentially
positive dying
experience
*PAS should be
legal in all states,
allowing the
patient to have
options

*Able to avoid a
“state worse than
death” by avoiding
physical suffering
using PAS
*Dying is a
subjective
experience; unable
to truly make broad
recommendations
*Important to
discuss every
available options
when a patient is
terminally ill to
allow the patient to
choose what is best
for them
*PAS meets the
patient’s desire to
control their death
experience and
avoid suffering

IV

CINAHL/Ebsco
World Host

*Family
perspective, not
the patients’;
unknown how
the patient
perceived his/her
experience
*Used valid
instrument

